DAC.NYSEDanaos CORP

SCHEDULE 13D/A: Danaos Corporation's Controlling Shareholder Updates Ownership Stake to 50.5% Following Company Share Repurchases

Sentiment:

Beneficial Ownership Update


An amendment to a Schedule 13D filing reveals that Danaos Investment Limited, as Trustee of the 883 Trust, and Dr. John Coustas, now beneficially own 50.5% of Danaos Corporation's common stock, primarily due to the company's share repurchase program.

Summary

  • Danaos Investment Limited as Trustee of the 883 Trust ("DIL") and Dr. John Coustas, collectively the Reporting Persons, beneficially own 9,338,502 shares of Danaos Corporation's Common Stock.
  • This ownership represents 50.5% of the outstanding shares of Common Stock, an increase in percentage primarily attributed to the Company's common stock repurchase program.
  • DIL, as Trustee of the 883 Trust, has sole voting and dispositive control over these shares.
  • Dr. Coustas is deemed to beneficially own these shares due to his power to remove and replace DIL as Trustee of the 883 Trust, though this does not imply economic ownership.
  • The beneficiaries of the 883 Trust include Dr. Coustas and members of his immediate family.
  • The board of directors of DIL consists of five members, none of whom are beneficiaries of the 883 Trust or members of the Coustas family.
  • Other individuals with beneficial ownership include Iraklis Prokopakis (200,270 shares, 1.1%), Evangelos Chatzis (50,000 shares, <1.0%), and Dimitrios Charkoplias (120 shares, <1.0%).
  • Evangelos Chatzis sold 23,000 shares of Common Stock for an aggregate sales price of $1.9 million between March 21 and March 25, 2025.

Sentiment

Score: 5

Explanation: The document is a factual update on beneficial ownership, primarily driven by the company's share repurchase program. It contains no explicit positive or negative financial performance news, maintaining a neutral sentiment.

Positives

  • The increase in the beneficial ownership percentage of the controlling shareholder (DIL and Dr. Coustas) to 50.5% is a result of the Company's common stock repurchase program, which can be positive for remaining shareholders by reducing the number of outstanding shares.
  • The board of directors of Danaos Investment Limited (DIL), the trustee of the 883 Trust, consists of five members, none of whom are beneficiaries of the 883 Trust or members of the Coustas family, suggesting a degree of independent oversight within the trust's governance.

Negatives

  • Evangelos Chatzis, a director of Danaos Investment Limited and Chief Financial Officer of Danaos Corporation, sold 23,000 shares for $1.9 million in open market transactions between March 21 and March 25, 2025, which could be perceived negatively by some investors.

Future Outlook

The document does not provide specific forward-looking statements or guidance regarding the company's future financial performance or strategic direction, beyond the ongoing common stock repurchase program which has influenced ownership percentages.

Industry Context

This Schedule 13D amendment primarily focuses on changes in beneficial ownership due to internal company actions (share repurchases) rather than broader industry trends. Danaos Corporation operates in the container shipping industry, and while the filing itself doesn't provide industry-specific insights, the company's share repurchase activity reflects its capital allocation strategy within the current market environment.

Related Party Transactions

  • The document references an Amended and Restated Management Agreement, dated February 3, 2025, between Danaos Corporation and Danaos Shipping Company Limited.
  • A Brokerage Services Agreement, dated February 3, 2025, among Danaos Corporation and Danaos Chartering Services Inc. is also referenced.
  • An Amended and Restated Restrictive Covenant Agreement, dated February 3, 2025, among Danaos Corporation, Dr. John Coustas, and DIL is mentioned.

Stakeholder Impact

  • Shareholders: The increase in the beneficial ownership percentage of the controlling shareholder due to company repurchases could be seen as a consolidation of control, potentially impacting minority shareholder influence. The share repurchase program itself generally benefits remaining shareholders by reducing the share count.
  • Management/Controlling Persons: Dr. John Coustas and Danaos Investment Limited maintain significant control over the company, reinforcing their strategic influence.

Key Dates

DateDescription
2010-08-16Original Schedule 13D filing date.
2018-08-14Amendment No. 1 filing date.
2019-12-02Amendment No. 2 filing date.
2021-09-14Amendment No. 3 filing date.
2022-04-15Amendment No. 4 filing date.
2023-11-15Amendment No. 5 filing date.
2024-11-13Amendment No. 6 filing date.
2025-01-16Amendment No. 7 filing date.
2025-02-03Date of Amended and Restated Management Agreement, Brokerage Services Agreement, and Amended and Restated Restrictive Covenant Agreement.
2025-03-05Date of Company's Annual Report on Form 20-F filing, where exhibits were incorporated by reference.
2025-03-21Start date of the period during which Mr. Chatzis sold shares.
2025-03-25End date of the period during which Mr. Chatzis sold shares.
2025-04-04Date of event which requires filing of this statement (Amendment No. 8).
2025-04-09Date of Joint Filing Agreement and signatures for Amendment No. 8.

Keywords

Danaos Corporation, Schedule 13D, Beneficial Ownership, Share Repurchase Program, Common Stock, SEC Filing, Corporate Governance, Trust Ownership, Shipping Industry

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.